Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Single Dose Preoperative Breast Stereotactic Body Radiation Therapy Using GammaPod for the Treatment of Early Stage Breast Cancer

Trial Status: active

This phase Ib trial evaluates a safe and effective dose of preoperative breast stereotactic body radiation therapy using the GammaPod machine to treat early stage breast cancer patients. Preoperative radiation therapy has been shown to reduce radiation treatment volumes (meaning the radiation covers a smaller portion of the body), improve cosmesis (skin changes), and shorten the course of radiation. For this trial, stereotactic body radiation therapy uses the GammaPod machine to position a patient and deliver radiation to tumors with high precision. A single dose of preoperative breast stereotactic body radiation therapy using the GammaPod machine may produce fewer side effects than standard treatment and improve cosmetic outcomes.